| RS1319458719 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS1319481399 |
POLG
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 4b, Progressive sclerosing poliodystrophy |
| RS1319489001 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1319491415 |
WRN
|
Health Risk |
Pathogenic/Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1319501039 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1319508199 |
HACE1
|
Health Risk |
Pathogenic |
Spastic paraplegia-severe developmental delay-epilepsy syndrome, Spastic paraplegia-severe developmental delay-epilepsy syndrome |
| RS1319513413 |
TIAM1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with language delay and seizures, Neurodevelopmental disorder with language delay and seizures |
| RS1319523217 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS1319547380 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1319548654 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypercholesterolemia |
| RS1319550069 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS1319555177 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS1319557765 |
HOXA13
|
Health Risk |
Conflicting classifications of pathogenicity |
Hand-foot-genital syndrome, Guttmacher syndrome |
| RS1319576439 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1319627398 |
PDE6B
|
Health Risk |
Likely pathogenic |
— |
| RS1319643225 |
SMPD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type B |
| RS1319646518 |
GUCA1A;GUCA1ANB-GUCA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone dystrophy 3, Cone dystrophy 3 |
| RS1319653117 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Inborn genetic diseases |
| RS1319653705 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal recessive form |
| RS1319653818 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS1319691084 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1319705053 |
IVD
|
Health Risk |
Likely pathogenic |
Isovaleryl-CoA dehydrogenase deficiency, Isovaleryl-CoA dehydrogenase deficiency |
| RS1319735007 |
COL5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1319739012 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1319747883 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS1319752625 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Danon disease, Cardiovascular phenotype |
| RS1319755767 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fumarase deficiency |
| RS1319771049 |
TGFBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1319778592 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1319783283 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS1319785257 |
MICU1
|
Health Risk |
Pathogenic |
— |
| RS1319786857 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1319792525 |
WFS1
|
Health Risk |
Pathogenic |
— |
| RS1319818753 |
SFTPA2
|
Health Risk |
Likely pathogenic |
Interstitial lung disease 2, Interstitial lung disease 2 |
| RS1319833991 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1319844752 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex with nail dystrophy, Epidermolysis bullosa simplex with nail dystrophy |
| RS1319872290 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1319877486 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia |
| RS1319888327 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1319889867 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1319907329 |
CCDC47
|
Health Risk |
Pathogenic |
Trichohepatoneurodevelopmental syndrome, Trichohepatoneurodevelopmental syndrome |
| RS1319910280 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS1319912400 |
CDKN1B
|
Health Risk |
Likely pathogenic |
— |
| RS1319938730 |
CYP27A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS1319938948 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS1319954878 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1320012238 |
TNFRSF11A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1320040467 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1320050201 |
MAK
|
Health Risk |
Pathogenic |
— |
| RS1320061495 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1320075163 |
BRAF
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS1320076769 |
CSPP1
|
Health Risk |
Pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS1320106244 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1320114611 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Progressive familial heart block type IB |
| RS1320125389 |
XYLT1
|
Health Risk |
Pathogenic |
Desbuquois dysplasia 1, Desbuquois dysplasia 1 |
| RS1320154351 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 27 |
| RS1320173977 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1320177911 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1320184173 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS1320208623 |
SMAD3
|
Health Risk |
Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1320218400 |
TRIP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Clark-Baraitser syndrome, Gastric cancer |
| RS1320246121 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1320278331 |
NEXMIF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1320283995 |
CCDC78
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myopathy with internal nuclei and atypical cores, Congenital myopathy with internal nuclei and atypical cores |
| RS1320317596 |
PDHB
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-beta deficiency, Pyruvate dehydrogenase E1-beta deficiency |
| RS1320323871 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1320325015 |
ABCC8
|
Health Risk |
Likely pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS1320326326 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1320329216 |
PCDHGC4
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with poor growth and skeletal anomalies, Neurodevelopmental disorder with poor growth and skeletal anomalies |
| RS1320349488 |
DSP
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS1320366310 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1320367366 |
AFG3L2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic ataxia, Spastic ataxia |
| RS1320376090 |
TYR
|
Health Risk |
Pathogenic/Likely pathogenic |
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN |
| RS1320387840 |
CUX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Global developmental delay with or without impaired intellectual development, Global developmental delay with or without impaired intellectual development |
| RS1320400029 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1320401077 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1320406415 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS1320406417 |
CAPN3
|
Health Risk |
Pathogenic |
Muscular dystrophy, limb-girdle |
| RS1320406513 |
OTOF
|
Health Risk |
Pathogenic |
Auditory neuropathy, Auditory neuropathy |
| RS1320417829 |
NDRG1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1320425016 |
PPT1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1320434721 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1320456072 |
DSP
|
Health Risk |
Pathogenic/Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS1320466105 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia, autosomal recessive |
| RS1320473430 |
SCYL1
|
Health Risk |
Pathogenic |
Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome, Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome |
| RS1320483615 |
COLQ
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome |
| RS1320510912 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1320531023 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome, Cardiac arrhythmia |
| RS1320536163 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1320543506 |
NPHS2
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 2 |
| RS1320549584 |
NPC2
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C2 |
| RS1320568689 |
SCN9A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS1320581229 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1320588121 |
ALDH3A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS1320594065 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1320610655 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome |
| RS1320628240 |
TRIM32
|
Health Risk |
Likely pathogenic |
— |
| RS1320661924 |
CDAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type I |
| RS1320663265 |
SPAST
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1320697469 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |